Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
Tang CPS, Lip GYH, McCormack T, Lyon AR, Hillmen P, Iyengar S, Martinez-Calle N, Parry-Jones N, Patten PEM, Schuh A, Walewska R; BSH guidelines committee, UK CLL Forum.
Tang CPS, et al. Among authors: mccormack t.
Br J Haematol. 2022 Jan;196(1):70-78. doi: 10.1111/bjh.17788. Epub 2021 Sep 8.
Br J Haematol. 2022.
PMID: 34498258
Review.
No abstract available.